Detailed introduction to the efficacy and functions of Obeticholic acid tablets

Obeticholic acid(Obeticholic acid) is an innovative farnesoid X receptor (FXR) agonist, mainly used to treat Primary Biliary Cholangitis (Primary Biliary Cholangitis, PBC) and some patients with liver diseases associated with cholestasis. FXR is a nuclear receptor that plays a key regulatory role in the liver and biliary system. It regulates bile acid synthesis, bile secretion, and liver fibrosis. By selectively activating FXR, obeticholic acid can reduce bile acid synthesis, promote bile excretion, and reduce liver cell damage, thereby improving patients' liver function indicators.

In terms of mechanism, obeticholic acid not only inhibits the accumulation of toxic bile acids in the liver, but also reduces the release of inflammatory mediators, reduces the inflammatory response of bile ducts and liver tissue, and delays the progression of liver fibrosis. Long-term use can improve patients' serum alkaline phosphatase (ALP), bilirubin and liver enzyme indicators, which is of great significance for PBC patients to maintain stable liver function and prevent disease progression to cirrhosis or end-stage liver disease. In addition, obeticholic acid's bidirectional effect on bile acid regulation can also improve patients' itching symptoms, which is one of the common clinical problems of PBC patients.

Clinically, obeticholic acid is usually used in patients with poor efficacy of ursodeoxycholic acid (UDCA), or is used in combination with UDCA to enhance the therapeutic effect. FXR activation is also closely related to metabolic regulation, which can improve liver lipid metabolism and anti-inflammatory effects to a certain extent, improving the overall liver environment of patients. Studies have shown that obeticholic acid reduces liver fibrosis scores and may delay disease progression to liver transplantation.

The dosage and administration of obeticholic acid tablets need to be guided by a doctor. Generally, the starting dose is lower, and the best effect can be achieved through gradual adjustment while reducing the risk of adverse reactions such as itching and lipid elevation. Since its mechanism of action involves the regulation of nuclear receptors, it usually takes weeks to months for the efficacy to appear, so patients need to maintain regular medication and regular review.

Reference materials:https://en.wikipedia.org/wiki/Obeticholic_acid